...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Announces Webcast Presentation at the BIO Investor Forum

The cone of silence has stopped, I assuming it is the same old review of old news but maybe  they have something new to announce, something  big perhaps...    nahhhh  , I have ben disappointed waytoo many times so why would they change now...

Share
New Message
Please login to post a reply